NXY-059

DRUG3 trials

Sponsors

AstraZeneca

Conditions

Cerebral StrokeCerebrovascular StrokeIntracerebral HemorrhageIschemic Attack, TransientStroke, Acute

Phase 2

Safety of NXY-059 for the Treatment of Patients Who Have Suffered From a Stroke

CompletedNCT00075959

AstraZenecaIntracerebral Hemorrhage

Start: 2004-08-31End: 2006-01-31Target: 600Updated: 2013-01-04

Phase 3

Safety and Effectiveness of NXY-059 for the Treatment of Patients Who Have Suffered From a Stroke

CompletedNCT00061022

AstraZenecaCerebral Stroke, Cerebrovascular Stroke, Ischemic Attack, Transient +1

Start: 2003-05-31End: 2006-09-30Target: 3200Updated: 2010-11-15

Safety and Effectiveness of NXY-059 for the Treatment of Patients Who Have Suffered From a Stroke

CompletedNCT00119626

AstraZenecaCerebral Stroke, Ischemic Attack, Transient

Start: 2003-06-30End: 2005-02-28Target: 1700Updated: 2010-11-15

Related Papers

NXY-059 for the treatment of acute ischemic stroke.

2007-08-01487 citations

NXY-059 for acute ischemic stroke.

2006-02-01452 citations